Vigna-Pérez, M <br/><br/>
Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis.  [electronic resource] 

 -  Clinical and experimental immunology  Aug 2005 
 - 372-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9104 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2249.2005.02859.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antigens, Bacterial--immunology<br/>Antirheumatic Agents--therapeutic use<br/>Apoptosis--drug effects<br/>Arthritis, Rheumatoid--drug therapy<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cells, Cultured<br/>Female<br/>Humans<br/>Immune Tolerance--drug effects<br/>Lymphocyte Count<br/>Middle Aged<br/>Mycobacterium tuberculosis--immunology<br/>Pilot Projects<br/>T-Lymphocyte Subsets--drug effects<br/>Tuberculin Test<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors